NAMS
NewAmsterdam Pharma Company N.V.
$38.07
+$1.02(+2.75%)
62
Overall
55
Value
100
Tech
31
Quality
Market Cap
$3.63B
Volume
2.25M
52W Range
$14.06 - $37.07
Target Price
$40.55
EPS Estimates Overview
| Current Quarter | $-0.41 | Next Quarter | $-0.37 |
| Current Year | $-1.47 | Next Year | $-2.06 |
| QoQ Growth | +9.8% | YoY Growth | -40.1% |
| 3Y EPS CAGR | -63.3% | Target Price | $40.55 |
| Consensus | Buy | Upside | +6.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $38.07 | +2.8% | 2.25M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW